RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 114.23

Change

+0.54 (+0.47)%

Market Cap

N/A

Volume

2.00K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+3.98 (+12.78%)

USD 11.53B
QLD ProShares Ultra QQQ

+4.80 (+5.11%)

USD 5.39B
FNGU MicroSectors FANG+ Index 3X Le..

+39.02 (+10.21%)

USD 5.13B
SSO ProShares Ultra S&P500

+2.94 (+3.42%)

USD 4.50B
UPRO ProShares UltraPro S&P500

+4.09 (+5.08%)

USD 3.53B
TECL Direxion Daily Technology Bull..

+6.52 (+8.36%)

USD 3.15B
LABU Direxion Daily S&P Biotech Bul..

+6.50 (+4.73%)

USD 0.94B
USD ProShares Ultra Semiconductors

+8.45 (+7.99%)

USD 0.86B
DPST Direxion Daily Regional Banks ..

+8.40 (+8.17%)

USD 0.77B
YINN Direxion Daily FTSE China Bull..

+2.27 (+10.41%)

USD 0.76B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+1.17 (+0%)

USD 0.10B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

+1.23 (+0%)

USD 9.12B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

+5.10 (+0%)

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.24B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

+0.82 (+0%)

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 24.97% 58% F 87% B+
Dividend Return 0.57% 31% F 11% F
Total Return 25.54% 58% F 85% B
Trailing 12 Months  
Capital Gain 34.33% 32% F 83% B
Dividend Return 0.81% 24% F 10% F
Total Return 35.13% 32% F 81% B-
Trailing 5 Years  
Capital Gain 121.25% 80% B- 89% A-
Dividend Return 2.33% 40% F 7% C-
Total Return 123.58% 80% B- 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.44% 42% F 79% B-
Dividend Return 15.66% 39% F 76% C+
Total Return 0.22% 21% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 27.10% 96% N/A 38% F
Risk Adjusted Return 57.76% 93% A 76% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.